Equity strategies

Carmignac Portfolio Investissement

Luxembourg SICAV sub-fundGlobal marketArticle 8
Share Class

LU1299311677

Global equities - broad in perspective, selective by conviction
  • An unconstrained approach in terms of sectors, regions, or investment style.
  • Stock selection based on companies that excel, are undervalued, and display a long-term potential.
  • Focus on secular growth profile driven by innovation, technology and a unique selling proposition.
Key documents
Asset Allocation
Equities98.1 %
Other1.9 %
Data as of:  Feb 27, 2026.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 170.9 %
+ 190.5 %
+ 51.5 %
+ 72.9 %
+ 39.0 %
From 19/11/2015
To 08/04/2026
Calendar Year Performance 2025
+ 3.5 %
+ 6.5 %
- 11.8 %
+ 28.0 %
+ 36.3 %
+ 5.1 %
- 15.8 %
+ 21.6 %
+ 26.8 %
+ 17.9 %
Net Asset Value
270.95 $
Asset Under Management
285 M €
Net Equity Exposure27/02/2026
87.5 %
SFDR - Fund Classification

Article

8
Data as of:  Apr 8, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team

Kristofer BARRETT

Head of Global Equities, Fund Manager
Source and Copyright: Citywire. Kristofer BARRETT is + rated by Citywire for his/her rolling three-year risk-adjusted performance across all funds the manager is managing to the January 31, 2026. Citywire Fund Manager Ratings and Citywire Rankings are proprietary to Citywire Financial Publishers Ltd (“Citywire”) and © Citywire 2025. All rights reserved. The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager. Past performance is not necessarily indicative of future performance.
Since its creation in 1989 by Edouard Carmignac, our Investissement strategy seeks to identify long-term trends in a changing world and seize global equity market opportunities.
View Fund's characteristics

Carmignac Portfolio Investissement fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  Mar 31, 2026.
Fund management team

Kristofer BARRETT

Head of Global Equities, Fund Manager
Source and Copyright: Citywire. Kristofer BARRETT is + rated by Citywire for his/her rolling three-year risk-adjusted performance across all funds the manager is managing to the January 31, 2026. Citywire Fund Manager Ratings and Citywire Rankings are proprietary to Citywire Financial Publishers Ltd (“Citywire”) and © Citywire 2025. All rights reserved. The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager. Past performance is not necessarily indicative of future performance.

Market environment

  • March 2026 was a clear risk-off month for global equities. The main catalyst was the escalation of the U.S.-Iran conflict, which pushed oil sharply higher, revived inflation fears and lifted yields.
  • In this context, central banks have adopted a more cautious stance, with investors now anticipating three rate hikes by the European Central Bank by the end of the year, and no longer expecting any easing from the Federal Reserve.
  • The first inflation data for the eurozone showed an initial impact of the conflict, with consumer prices rising by +2.5% year-on-year in March compared to +1.9% at the end of February while in the US, economic data remain resilient, both in the labor market and in leading indicators.
  • The selloff was broad-based but uneven: U.S. equities entered a sharp correction, Europe posted its worst month since 2022, and Emerging Markets recorded the deepest drawdowns.
  • Asian and European markets underperformance reflect their higher sensitivity to energy supply risks, with Korea emerging as the weakest market.
  • Energy was the only sector to deliver positive returns, while all other major sectors declined.
  • The technology sector remained under pressure due to the sharp rise in bond yields, although it was no longer the main driver of the overall market weakness.

Performance commentary

  • In this context, our strategy delivered a negative performance, slightly below that of its reference indicator over the period.
  • This performance was primarily driven by a negative beta effect, in an environment where global and emerging equity markets declined.
  • The main detractor was our technology portfolio, particularly SK Hynix and SK Square. Although Korean memory manufacturers have limited exposure to rising energy prices, their share prices corrected significantly due to profit-taking following strong gains since the beginning of the year. TSMC also declined over the month.
  • Our positions in the healthcare sector also weighed on performance, notably McKesson and Cencora, while our underweight in energy stocks further penalised relative performance in a context of rising energy prices.
  • Finally, our option strategies contributed positively to performance over the period.

Outlook strategy

  • Looking ahead, uncertainty is likely to remain elevated as long as tensions in the Middle East persist, with market dispersion expected to stay high. At this stage, markets appear to be pricing in an inflation shock, but not yet a meaningful slowdown in growth. The duration of the conflict will be key, as a prolonged disruption could increase the risk of more persistent economic damage.
  • Any market dislocation unconnected to underlying fundamentals can create an attractive entry point. More broadly, we remain tilted towards high-quality factors while maintaining a cautious stance on the portfolio’s overall valuation.
  • In technology, recent corrections have been significant. We remain constructive on semiconductors, supported by resilient demand dynamics, while adopting a more selective approach given valuation levels (TSMC, SK Hynix).
  • In financials, we have reinforced exposure to companies we believe are overly discounted in the context of AI disruption concerns, while also maintaining defensive exposure through names such as Berkshire Hathaway.
  • In industrials, we continue to focus on long-term structural themes such as electrification and aerospace, taking advantage of market weakness to build positions (Schneider Electric, Airbus).
  • Finally, in healthcare, we maintain a balanced exposure across defensive segments and high-quality biotech companies supported by solid fundamentals. (Mckesson, Cencora, Vertex Pharmaceuticals)

Performance Overview

Data as of:  Apr 8, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 09/04/2026

Carmignac Portfolio Investissement Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  Feb 27, 2026.
North America57.3 %
Asia25.8 %
Europe13.0 %
Latin America2.3 %
Asia-Pacific1.0 %
Middle East0.3 %
Eastern Europe0.2 %
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  Feb 27, 2026.
Equity Investment Weight98.1 %
Net Equity Exposure87.5 %
Number of Equity Issuers80
Active Share78.6 %

Articles that may interest you

[Background image] [CI] Blue sky and buildings
Strategies insightsFebruary 3, 2026English

Carmignac Investissement: Letter from the Fund Manager - Q4 2025

3 minute(s) read
Find out more
Our viewsJanuary 30, 2026English

Annual Meeting 2026: Key Messages

3 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
​The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.